Owners of SYNDAX PHARMACEUTICALS in Q2 2021

Owners of SYNDAX PHARMACEUTICALS in Q2 2021
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 875,000$15,0244.13%
Aisling Capital Management LP 1,025,000$17,5992.82%
Avidity Partners Management LP 4,615,000$79,2402.14%
FRAZIER MANAGEMENT LLC 1,188,135$20,4001.88%
BVF INC/IL 2,486,429$42,6921.60%
ACUTA CAPITAL PARTNERS, LLC 206,126$3,5391.41%
Boxer Capital, LLC 2,287,782$39,2811.39%
Nantahala Capital Management 2,593,337$44,5281.26%
HealthCor Management, L.P. 1,751,342$30,0711.20%
PFM Health Sciences, LP 2,144,881$36,8281.15%
Avoro Capital Advisors LLC 3,000,000$51,5100.90%
683 Capital Management, LLC 1,085,900$18,6440.64%
SPHERA FUNDS MANAGEMENT LTD. 547,187$9,3950.64%
HighVista Strategies LLC 47,814$8210.58%
DAFNA Capital Management LLC 147,702$2,5360.53%
Casdin Capital, LLC 1,200,000$20,6040.52%
DUMAC, INC. 21,240$3650.41%
Palo Alto Investors LP 401,100$6,8870.38%
SILVERARC CAPITAL MANAGEMENT, LLC 34,727$5960.27%
Vivo Capital, LLC 320,000$5,4940.24%

This page lists all the filers that owned SYNDAX PHARMACEUTICALS in Q2 2021. For a list of filers that in the past have reported owning SYNDAX PHARMACEUTICALS, see the History page.